64,043 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by Bryce Point Capital LLC

Bryce Point Capital LLC bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 64,043 shares of the medical instruments supplier's stock, valued at approximately $1,216,000.

A number of other hedge funds also recently made changes to their positions in the stock. Pacer Advisors Inc. boosted its stake in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the period. Nuance Investments LLC boosted its position in shares of DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Norges Bank bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at $45,730,000. Cooke & Bieler LP lifted its stake in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after purchasing an additional 1,794,391 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after purchasing an additional 1,244,326 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.52% of the stock is currently owned by corporate insiders.

Remove Ads

DENTSPLY SIRONA Stock Up 1.1 %

Shares of DENTSPLY SIRONA stock traded up $0.14 on Tuesday, reaching $13.38. The stock had a trading volume of 746,822 shares, compared to its average volume of 2,923,717. The company has a 50 day moving average price of $17.01 and a 200 day moving average price of $19.61. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1 year low of $12.54 and a 1 year high of $33.02. The stock has a market capitalization of $2.66 billion, a P/E ratio of -6.45, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.78%. DENTSPLY SIRONA's payout ratio is -14.07%.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. StockNews.com cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Evercore ISI restated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Wells Fargo & Company lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Mizuho decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, Robert W. Baird cut their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.